- •Preface
- •Acknowledgments
- •Contents
- •1.1 Introduction
- •1.2 Normal Embryology
- •1.3 Abnormalities of the Kidney
- •1.3.1 Renal Agenesis
- •1.3.2 Renal Hypoplasia
- •1.3.3 Supernumerary Kidneys
- •1.3.5 Polycystic Kidney Disease
- •1.3.6 Simple (Solitary) Renal Cyst
- •1.3.7 Renal Fusion and Renal Ectopia
- •1.3.8 Horseshoe Kidney
- •1.3.9 Crossed Fused Renal Ectopia
- •1.4 Abnormalities of the Ureter
- •1.5 Abnormalities of the Bladder
- •1.6 Abnormalities of the Penis and Urethra in Males
- •1.7 Abnormalities of Female External Genitalia
- •Further Reading
- •2.1 Introduction
- •2.2 Pathophysiology
- •2.3 Etiology of Hydronephrosis
- •2.5 Clinical Features
- •2.6 Investigations and Diagnosis
- •2.7 Treatment
- •2.8 Antenatal Hydronephrosis
- •Further Reading
- •3.1 Introduction
- •3.2 Embryology
- •3.3 Pathophysiology
- •3.4 Etiology of PUJ Obstruction
- •3.5 Clinical Features
- •3.6 Diagnosis and Investigations
- •3.7 Management of Newborns with PUJ Obstruction
- •3.8 Treatment
- •3.9 Post-operative Complications and Follow-Up
- •Further Reading
- •4: Renal Tumors in Children
- •4.1 Introduction
- •4.2 Wilms’ Tumor
- •4.2.1 Introduction
- •4.2.2 Etiology
- •4.2.3 Histopathology
- •4.2.4 Nephroblastomatosis
- •4.2.5 Clinical Features
- •4.2.6 Risk Factors for Wilms’ Tumor
- •4.2.7 Staging of Wilms Tumor
- •4.2.8 Investigations
- •4.2.9 Prognosis and Complications of Wilms Tumor
- •4.2.10 Surgical Considerations
- •4.2.11 Surgical Complications
- •4.2.12 Prognosis and Outcome
- •4.2.13 Extrarenal Wilms’ Tumors
- •4.3 Mesoblastic Nephroma
- •4.3.1 Introduction
- •4.3.3 Epidemiology
- •4.3.5 Clinical Features
- •4.3.6 Investigations
- •4.3.7 Treatment and Prognosis
- •4.4 Clear Cell Sarcoma of the Kidney (CCSK)
- •4.4.1 Introduction
- •4.4.2 Pathophysiology
- •4.4.3 Clinical Features
- •4.4.4 Investigations
- •4.4.5 Histopathology
- •4.4.6 Treatment
- •4.4.7 Prognosis
- •4.5 Malignant Rhabdoid Tumor of the Kidney
- •4.5.1 Introduction
- •4.5.2 Etiology and Pathophysiology
- •4.5.3 Histologic Findings
- •4.5.4 Clinical Features
- •4.5.5 Investigations and Diagnosis
- •4.5.6 Treatment and Outcome
- •4.5.7 Mortality/Morbidity
- •4.6 Renal Cell Carcinoma in Children
- •4.6.1 Introduction
- •4.6.2 Histopathology
- •4.6.4 Staging
- •4.6.5 Clinical Features
- •4.6.6 Investigations
- •4.6.7 Management
- •4.6.8 Prognosis
- •4.7 Angiomyolipoma of the Kidney
- •4.7.1 Introduction
- •4.7.2 Histopathology
- •4.7.4 Clinical Features
- •4.7.5 Investigations
- •4.7.6 Treatment and Prognosis
- •4.8 Renal Lymphoma
- •4.8.1 Introduction
- •4.8.2 Etiology and Pathogenesis
- •4.8.3 Diagnosis
- •4.8.4 Clinical Features
- •4.8.5 Treatment and Prognosis
- •4.9 Ossifying Renal Tumor of Infancy
- •4.10 Metanephric Adenoma
- •4.10.1 Introduction
- •4.10.2 Histopathology
- •4.10.3 Diagnosis
- •4.10.4 Clinical Features
- •4.10.5 Treatment
- •4.11 Multilocular Cystic Renal Tumor
- •Further Reading
- •Wilms’ Tumor
- •Mesoblastic Nephroma
- •Renal Cell Carcinoma in Children
- •Angiomyolipoma of the Kidney
- •Renal Lymphoma
- •Ossifying Renal Tumor of Infancy
- •Metanephric Adenoma
- •Multilocular Cystic Renal Tumor
- •5.1 Introduction
- •5.2 Embryology
- •5.4 Histologic Findings
- •5.7 Associated Anomalies
- •5.8 Clinical Features
- •5.9 Investigations
- •5.10 Treatment
- •Further Reading
- •6: Congenital Ureteral Anomalies
- •6.1 Etiology
- •6.2 Clinical Features
- •6.3 Investigations and Diagnosis
- •6.4 Duplex (Duplicated) System
- •6.4.1 Introduction
- •6.4.3 Clinical Features
- •6.4.4 Investigations
- •6.4.5 Treatment and Prognosis
- •6.5 Ectopic Ureter
- •6.5.1 Introduction
- •6.5.3 Clinical Features
- •6.5.4 Diagnosis
- •6.5.5 Surgical Treatment
- •6.6 Ureterocele
- •6.6.1 Introduction
- •6.6.3 Clinical Features
- •6.6.4 Investigations and Diagnosis
- •6.6.5 Treatment
- •6.6.5.1 Surgical Interventions
- •6.8 Mega Ureter
- •Further Reading
- •7: Congenital Megaureter
- •7.1 Introduction
- •7.3 Etiology and Pathophysiology
- •7.4 Clinical Presentation
- •7.5 Investigations and Diagnosis
- •7.6 Treatment and Prognosis
- •7.7 Complications
- •Further Reading
- •8.1 Introduction
- •8.2 Pathophysiology
- •8.4 Etiology of VUR
- •8.5 Clinical Features
- •8.6 Investigations
- •8.7 Management
- •8.7.1 Medical Treatment of VUR
- •8.7.2 Antibiotics Used for Prophylaxis
- •8.7.3 Anticholinergics
- •8.7.4 Surveillance
- •8.8 Surgical Therapy of VUR
- •8.8.1 Indications for Surgical Interventions
- •8.8.2 Indications for Surgical Interventions Based on Age at Diagnosis and the Presence or Absence of Renal Lesions
- •8.8.3 Endoscopic Injection
- •8.8.4 Surgical Management
- •8.9 Mortality/Morbidity
- •Further Reading
- •9: Pediatric Urolithiasis
- •9.1 Introduction
- •9.2 Etiology
- •9.4 Clinical Features
- •9.5 Investigations
- •9.6 Complications of Urolithiasis
- •9.7 Management
- •Further Reading
- •10.1 Introduction
- •10.2 Embryology of Persistent Müllerian Duct Syndrome
- •10.3 Etiology and Inheritance of PMDS
- •10.5 Clinical Features
- •10.6 Treatment
- •10.7 Prognosis
- •Further Reading
- •11.1 Introduction
- •11.2 Physiology and Bladder Function
- •11.2.1 Micturition
- •11.3 Pathophysiological Changes of NBSD
- •11.4 Etiology and Clinical Features
- •11.5 Investigations and Diagnosis
- •11.7 Management
- •11.8 Clean Intermittent Catheterization
- •11.9 Anticholinergics
- •11.10 Botulinum Toxin Type A
- •11.11 Tricyclic Antidepressant Drugs
- •11.12 Surgical Management
- •Further Reading
- •12.1 Introduction
- •12.2 Etiology
- •12.3 Pathophysiology
- •12.4 Clinical Features
- •12.5 Investigations and Diagnosis
- •12.6 Management
- •Further Reading
- •13.1 Introduction
- •13.2 Embryology
- •13.3 Epispadias
- •13.3.1 Introduction
- •13.3.2 Etiology
- •13.3.4 Treatment
- •13.3.6 Female Epispadias
- •13.3.7 Surgical Repair of Female Epispadias
- •13.3.8 Prognosis
- •13.4 Bladder Exstrophy
- •13.4.1 Introduction
- •13.4.2 Associated Anomalies
- •13.4.3 Principles of Surgical Management of Bladder Exstrophy
- •13.4.4 Evaluation and Management
- •13.5 Cloacal Exstrophy
- •13.5.1 Introduction
- •13.5.2 Skeletal Changes in Cloacal Exstrophy
- •13.5.3 Etiology and Pathogenesis
- •13.5.4 Prenatal Diagnosis
- •13.5.5 Associated Anomalies
- •13.5.8 Surgical Reconstruction
- •13.5.9 Management of Urinary Incontinence
- •13.5.10 Prognosis
- •13.5.11 Complications
- •Further Reading
- •14.1 Introduction
- •14.2 Etiology
- •14.3 Clinical Features
- •14.4 Associated Anomalies
- •14.5 Diagnosis
- •14.6 Treatment and Prognosis
- •Further Reading
- •15: Cloacal Anomalies
- •15.1 Introduction
- •15.2 Associated Anomalies
- •15.4 Clinical Features
- •15.5 Investigations
- •Further Reading
- •16: Urachal Remnants
- •16.1 Introduction
- •16.2 Embryology
- •16.4 Clinical Features
- •16.5 Tumors and Urachal Remnants
- •16.6 Management
- •Further Reading
- •17: Inguinal Hernias and Hydroceles
- •17.1 Introduction
- •17.2 Inguinal Hernia
- •17.2.1 Incidence
- •17.2.2 Etiology
- •17.2.3 Clinical Features
- •17.2.4 Variants of Hernia
- •17.2.6 Treatment
- •17.2.7 Complications of Inguinal Herniotomy
- •17.3 Hydrocele
- •17.3.1 Embryology
- •17.3.3 Treatment
- •Further Reading
- •18: Cloacal Exstrophy
- •18.1 Introduction
- •18.2 Etiology and Pathogenesis
- •18.3 Associated Anomalies
- •18.4 Clinical Features and Management
- •Further Reading
- •19: Posterior Urethral Valve
- •19.1 Introduction
- •19.2 Embryology
- •19.3 Pathophysiology
- •19.5 Clinical Features
- •19.6 Investigations and Diagnosis
- •19.7 Management
- •19.8 Medications Used in Patients with PUV
- •19.10 Long-Term Outcomes
- •19.10.3 Bladder Dysfunction
- •19.10.4 Renal Transplantation
- •19.10.5 Fertility
- •Further Reading
- •20.1 Introduction
- •20.2 Embryology
- •20.4 Clinical Features
- •20.5 Investigations
- •20.6 Treatment
- •20.7 The Müllerian Duct Cyst
- •Further Reading
- •21: Hypospadias
- •21.1 Introduction
- •21.2 Effects of Hypospadias
- •21.3 Embryology
- •21.4 Etiology of Hypospadias
- •21.5 Associated Anomalies
- •21.7 Clinical Features of Hypospadias
- •21.8 Treatment
- •21.9 Urinary Diversion
- •21.10 Postoperative Complications
- •Further Reading
- •22: Male Circumcision
- •22.1 Introduction
- •22.2 Anatomy and Pathophysiology
- •22.3 History of Circumcision
- •22.4 Pain Management
- •22.5 Indications for Circumcision
- •22.6 Contraindications to Circumcision
- •22.7 Surgical Procedure
- •22.8 Complications of Circumcision
- •Further Reading
- •23: Priapism in Children
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Etiology
- •23.5 Clinical Features
- •23.6 Investigations
- •23.7 Management
- •23.8 Prognosis
- •23.9 Priapism and Sickle Cell Disease
- •23.9.1 Introduction
- •23.9.2 Epidemiology
- •23.9.4 Pathophysiology
- •23.9.5 Clinical Features
- •23.9.6 Treatment
- •23.9.7 Prevention of Stuttering Priapism
- •23.9.8 Complications of Priapism and Prognosis
- •Further Reading
- •24.1 Introduction
- •24.2 Embryology and Normal Testicular Development and Descent
- •24.4 Causes of Undescended Testes and Risk Factors
- •24.5 Histopathology
- •24.7 Clinical Features and Diagnosis
- •24.8 Treatment
- •24.8.1 Success of Surgical Treatment
- •24.9 Complications of Orchidopexy
- •24.10 Infertility and Undescended Testes
- •24.11 Undescended Testes and the Risk of Cancer
- •Further Reading
- •25: Varicocele
- •25.1 Introduction
- •25.2 Etiology
- •25.3 Pathophysiology
- •25.4 Grading of Varicoceles
- •25.5 Clinical Features
- •25.6 Diagnosis
- •25.7 Treatment
- •25.8 Postoperative Complications
- •25.9 Prognosis
- •Further Reading
- •26.1 Introduction
- •26.2 Etiology and Risk Factors
- •26.3 Diagnosis
- •26.4 Intermittent Testicular Torsion
- •26.6 Effects of Testicular Torsion
- •26.7 Clinical Features
- •26.8 Treatment
- •26.9.1 Introduction
- •26.9.2 Etiology of Extravaginal Torsion
- •26.9.3 Clinical Features
- •26.9.4 Treatment
- •26.10 Torsion of the Testicular or Epididymal Appendage
- •26.10.1 Introduction
- •26.10.2 Embryology
- •26.10.3 Clinical Features
- •26.10.4 Investigations and Treatment
- •Further Reading
- •27: Testicular Tumors in Children
- •27.1 Introduction
- •27.4 Etiology of Testicular Tumors
- •27.5 Clinical Features
- •27.6 Staging
- •27.6.1 Regional Lymph Node Staging
- •27.7 Investigations
- •27.8 Treatment
- •27.9 Yolk Sac Tumor
- •27.10 Teratoma
- •27.11 Mixed Germ Cell Tumor
- •27.12 Stromal Tumors
- •27.13 Simple Testicular Cyst
- •27.14 Epidermoid Cysts
- •27.15 Testicular Microlithiasis (TM)
- •27.16 Gonadoblastoma
- •27.17 Cystic Dysplasia of the Testes
- •27.18 Leukemia and Lymphoma
- •27.19 Paratesticular Rhabdomyosarcoma
- •27.20 Prognosis and Outcome
- •Further Reading
- •28: Splenogonadal Fusion
- •28.1 Introduction
- •28.2 Etiology
- •28.4 Associated Anomalies
- •28.5 Clinical Features
- •28.6 Investigations
- •28.7 Treatment
- •Further Reading
- •29: Acute Scrotum
- •29.1 Introduction
- •29.2 Torsion of Testes
- •29.2.1 Introduction
- •29.2.3 Etiology
- •29.2.4 Clinical Features
- •29.2.5 Effects of Torsion of Testes
- •29.2.6 Investigations
- •29.2.7 Treatment
- •29.3 Torsion of the Testicular or Epididymal Appendage
- •29.3.1 Introduction
- •29.3.2 Embryology
- •29.3.3 Clinical Features
- •29.3.4 Investigations and Treatment
- •29.4.1 Introduction
- •29.4.2 Etiology
- •29.4.3 Clinical Features
- •29.4.4 Investigations and Treatment
- •29.5 Idiopathic Scrotal Edema
- •29.6 Testicular Trauma
- •29.7 Other Causes of Acute Scrotum
- •29.8 Splenogonadal Fusion
- •Further Reading
- •30.1 Introduction
- •30.2 Imperforate Hymen
- •30.3 Vaginal Atresia
- •30.5 Associated Anomalies
- •30.6 Embryology
- •30.7 Clinical Features
- •30.8 Investigations
- •30.9 Management
- •Further Reading
- •31: Disorders of Sexual Development
- •31.1 Introduction
- •31.2 Embryology
- •31.3 Sexual and Gonadal Differentiation
- •31.5 Evaluation of a Newborn with DSD
- •31.6 Diagnosis and Investigations
- •31.7 Management of Patients with DSD
- •31.8 Surgical Corrections of DSD
- •31.9 Congenital Adrenal Hyperplasia (CAH)
- •31.10 Androgen Insensitivity Syndrome (Testicular Feminization Syndrome)
- •31.13 Gonadal Dysgenesis
- •31.15 Ovotestis Disorders of Sexual Development
- •31.16 Other Rare Disorders of Sexual Development
- •Further Reading
- •Index
88 |
3 Pelviureteric Junction (PUJ) Obstruction |
|
|
•Under fluoroscopy, the PUJ is assessed and drainage through this segment is evaluated.
•High intrarenal pressures is indicative of PUJ obstruction.
•Low intrarenal pressures in the presence of hydronephrosis are consistent with normal variance.
•The Whitaker test is a pressure flow study that has proven useful in equivocal PUJ obstruction in children.
•A catheter is introduced percutaneously into the renal pelvis. The patency of the PUJ is challenged fluid infusion via the catheter and simultaneously measuring the intrapelvic pressure.
3.7Management of Newborns with PUJ Obstruction
•The timing of surgical correction of PUJ obstruction in newborns is highly controversial.
•Immediate surgery is not necessary for those newborns with relatively preserved differential renal function (>40 % of differential renal function).
•These patients can be observed safely nonoperatively as in some of them the obstruction will resolve spontaneously.
•These patients should be covered with antibiotic prophylaxis.
–The use of antibiotic prophylaxis in mild hydronephrosis is still controversial.
–Most authors advocate antibiotic prophylaxis for those with moderate-to-severe hydronephrosis (SFU grade 3 or 4).
•Urinary tract infection in these patients increases the chance of fibrosis and parenchymal damage.
•Patients with renal function >40 % are monitored with repeat renal scans at 3- to 6-month and 12-month intervals, and surgery is performed only if a clear deterioration in renal function is present.
•In cases in which the differential function is <10 %, some recommend the insertion of a
nephrostomy tube to determine whether return of function will be sufficient.
•Others consider this a non-functioning kidney and there is no point in inserting a nephrostomy. Add to this the fact that nephrostomy is difficult to maintain in infants and children and it is known to be associated with bacteriuria.
•Nephrectomy is indicated in those with a differential function <10 % and complicated by hypertension or recurrent urinary tract infection.
•Surgical Therapy:
–Prolonged partial PUJ obstruction is deleterious to the newborn kidney and can be reversed by early relief of the obstruction.
–Spontaneous resolution of hydronephrosis although well known, 15–33 % of patients with asymptomatic neonatal hydronephrosis show progressive ipsilateral renal deterioration, and about one half of them never regain the lost function by pyeloplasty.
–There is a definite percentage of patients with PUJ obstruction treated conservatively who will sustain irreversible renal damage that could have been prevented by early pyeloplasty.
•Indications for surgical interventions in PUJ obstruction:
–Unilateral PUJ obstruction with less than 40 % of differential renal function on diuretic renograms.
–Bilateral severe PUJ obstruction with renal parenchymal atrophy.
–Obstructive pattern on diuretic renograms with abdominal mass, urosepsis, or other symptoms.
–Recurrent UTI under antibiotic prophylaxis.
•A temporary percutaneous nephrostomy was advocated in newborns with severe hydronephrosis. The aims of this include (Figs. 3.40, 3.41, 3.42 and 3.43):
–To confirm the diagnosis and document the severity of obstruction.
–To drain the obstructed kidney and relive the pressure on the renal parenchyma.
–Newborns and because of the partial PUJ obstruction have a small size ureter that
3.8 Treatment |
89 |
|
|
Figs. 3.40, 3.41, 3.42, and 3.43 Percutaneous nephrostograms showing unilateral and bilateral PUJ obstruction in newborns and infants (Note the degree of
obstruction and the extent of hydronephrosis. The nephrostomy is also useful for temporary drainage of the obstructed kidney)
makes it difficult operatively to reconstruct the new PUJ and placing a temporary nephrostomy will time to decompress the kidney, increase the size of the ureter and allow the child to grow.
–Nephrostomy tubes are also known to be associated with complications including sepsis, kinking and spontaneous dislodgment.
3.8Treatment
•The aims of treating patients with PUJ obstruction are:
–Relive the obstruction
–Improve renal drainage
–Maintain or improve the renal function
•There is no evidence that prenatal intervention in infants with either a single obstructed
90 |
3 Pelviureteric Junction (PUJ) Obstruction |
|
|
kidney or bilateral involvement improves renal outcome.
•Antenatal intervention however is recommended in those with extremely severe PUJ obstruction and only be done in centers with experienced surgeons as this may be associated with morbidity and fetal mortality.
•Asymptomatic patients with PUJ obstruction:
–The ultimate goal of management is to preserve renal function and avoid unnecessary surgery.
–Managing asymptomatic patients is challenging, because the natural course of PUJ obstruction is variable.
–It appears that many patients with PUJ obstruction will have stable renal function and improvement in the degree of hydronephrosis during long periods of observation.
–However, others will have deterioration of their renal function, and appear to benefit from surgical repair of PUJ obstruction.
–There is no reliable method to predict which patients with asymptomatic PUJ obstruction, their kidney function will deteriorated and whether the function of a kidney with PUJ obstruction will remain unaffected during the period of observation.
–As a result of this, there is controversy on the role of watchful observation with surgical intervention only in those who develop symptoms or if there is a decrease in renal function. This approach may prevent unnecessary surgery in some asymptomatic patients with PUJ obstruction.
–Patients with PUJ obstruction are monitored closely with renal ultrasonography and nuclear scans every 3–4 months.
–It is important to monitor the renal pelvic dilatation with serial ultrasounds. This is important to assess:
•Changes in renal pelvic dilatation
•Renal parenchymal thickness
•The presence of scarring, and function.
–Patients with asymptomatic PUJ obstruction should be monitored and followed-up with serial renal ultrasounds to detect any
change in the degree of hydronephrosis that may necessitate surgical intervention.
•Renal ultrasound evaluations are performed every 3–4 months until the
child reaches 1 year of age, every 6 months for the next 2 years, and then annually.
•If the renal ultrasound shows increasing hydronephrosis, a diuretic renogram is repeated to detect any change in renal function or confirm that the renal function is stable.
•If diuretic renogram shows deterioration of >10 % in the renal function on the affected side, or the relative renal function is <40 %, surgery is recommended.
•These studies are performed more frequently (every 2–3 months) if the relative renal function is borderline, and significant hydronephrosis is present.
–The problem is more complicated in those with bilateral asymptomatic PUJ obstruction as the relative renal function may not be a reliable measure.
–In these patients, glomerular filtration rate can be measured with serum creatinine and/or by renal scan. If renal function is significantly decreased, surgery is indicated to relieve PUJ obstruction.
–Antibiotic prophylaxis:
•This has been recommended in these patients because urinary stasis is believed to be a risk factor for urinary tract infection.
•This is also controversial and does not appear that it is beneficial in children with PUJ obstruction especially those with mild PUJ obstruction.
•There are those who advocate giving antibiotic prophylaxis for patients with severe, grade IV hydronephrosis until the time of the voiding cystourethrogram (VCUG). If the VCUG does not show vesicoureteral reflux, the prophylactic antibiotics are discontinued.
•Others will give prophylaxis antibiotics for all patients with PUJ obstruction.
3.8 Treatment |
91 |
|
|
•Children with PUJ obstruction who are symptomatic require operative intervention.
•Kidney stones sometimes develop in those with PUJ obstruction and these patients should be treated with open pyelolithotomy and pyeloplasty.
•Patients with PUJ obstruction who present with acute pyelonephritis are treated first with antibiotics. Surgical repair is performed when the infection has resolved but if pyelonephritis does not respond to antibiotics, a temporary percutaneous nephrostomy should be placed to drain the kidney and relieve the obstruction.
•Initially, most children with incomplete PUJ obstruction are treated conservatively and monitored closely.
•Monitoring of these patients include serial renal ultrasonography and renal isotope scan.
•Surgical intervention is indicated in patients with PUJ obstruction:
–Who are symptomatic (pain, hypertension, hematuria, secondary renal calculi, and recurrent urinary tract infections).
–With significantly impaired renal drainage or poor renal growth
–With deterioration of renal function (a serial loss in renal function >10 %).
–With clearance half-time (T 1/2) greater than 20 min, differential function less than
40 %, and ongoing parenchymal thinning with or without contralateral compensatory hypertrophy.
–With progressive increase in the size of renal pelvis on serial imaging.
–With bilateral PUJ obstruction and thinning of renal parenchyma.
•There are several methods to treat PUJ obstruction.
•Open surgical Therapy (Fig. 3.44):
Asymptomatic Patients with PUJ Obstruction
•Observation is appropriate for asymptomatic patients with PUJ obstruction and hydronephrosis that is mild to moderate in severity (i.e. Society of Fetal Urology [SFU] grade II to III).
•These patients are followed-up with ultrasound examination every 4 (Grade
III)to 6 (Grade II) months in the first year of life, then every 12–18 months thereafter.
•If there is an increase in the degree of hydronephrosis, a diuretic renogram is performed.
•If the affected kidney has <40 % of split renal function, or there is a serial loss
PUJ OBSTRUCTION
URETER |
DILATED RENAL |
|
|
|
PELVIS |
Fig. 3.44 An intraoperative photograph showing hydronephrosis secondary to PUJ
92 |
3 Pelviureteric Junction (PUJ) Obstruction |
|
|
>10 % from a previous study, surgical intervention is recommended.
•Newborns who have persistent SFU grade IV hydronephrosis require closer observation and frequent renal ultrasound follow-up.
•In these patients, a diuretic renogram is performed at 6–8 weeks of age.
–If the hydronephrotic kidney has decreased renal function (<40 % of split renal function) compared with its normal contralateral side, surgical intervention is recommended.
–If the hydronephrotic kidney have equal function compared with the normal contralateral kidney, the renal sonogram is repeated in 4–6 weeks. If the sonogram shows improvement, these patients are followed-up with serial renal ultrasounds at 3–4 month intervals.
–Any worsening of the hydronephrosis calls for a diuretic renogram.
–If these serial sonograms show continued SFU grade IV hydronephrosis without substantial change from previous studies:
•Continued observation and monitoring including renal ultrasound and diuretic renograms
•If the family prefer, surgical intervention is recommended.
–In 1936, Foley introduced the YV-plasty for the correction of PUJ obstruction.
–Culp and DeWeerd designed a spiral flap in the dilated pelvis and used it to repair the defect of the PUJ.
–The Foley Y-V plasty is used to treat PUJ obstruction and those with the high-insertion variant but cannot be used in the presence of apparent lower-pole vessel.
–Spiral and vertical flaps (e.g. Culp and DeWeerd, Scardino and Prince) are useful for those with a long-strictured segment of the ureter. The proximal strictured ureter is
re-tubularized using the redundant renal pelvis.
–In 1946, Anderson and Hynes described their operation to treat PUJ obstruction. The Anderson-Hynes dismembered pyeloplasty is currently the most commonly used procedure to repair PUJ obstruction.
–In children, the procedure of choice to treat PUJ obstruction is an Anderson-Hynes dismembered pyeloplasty.
–The Anderson-Hynes dismembered pyeloplasty is particularly useful for those with the high-insertion variant of PUJ obstruction.
Indications for Surgery in PUJ Obstruction
•Symptomatic patients (flank pain, urinary tract infection, and renal stones).
•Unilateral PUJ obstruction with <40 % of differential renal function on diuretic renograms or there is a serial loss in renal function >10 %.
•Bilateral severe PUJ obstruction with renal parenchymal atrophy.
•Obstructive pattern on diuretic renograms with abdominal mass, urosepsis, or other symptoms (e.g., cyclic flank pain, nausea, vomiting).
•Recurrent UTI in spite of antibiotic prophylaxis.
•Massive hydronephrosis (renal pelvis diameter >4–5 cm.
•Parental preference in those who require frequent observation and invasive testing.
Patients with renal function more than 40 % on the affected side are monitored with repeat renal scans at 3- to 6-month and 12-month intervals, and surgery is performed only if a clear deterioration in renal function is present.
3.8 Treatment |
93 |
|
|
Patients with Renal Differential Function <10 %
•Some recommend insertion of a nephrostomy tube to determine whether return of function will be sufficient.
•Others consider nephrectomy to relieve recurrent infection or renal hypertension.
•In the absence of significant hydronephrosis, some surgeons will observe these patients and will consider nephrectomy only if they develop hypertension or recurrent urinary tract infection.
–In this technique, the obstructed segment is completely resected, the renal pelvis is tapered with reanastomosis of the renal pelvis and ureter in a dependent funneled fashion.
–The decision of whether to use a ureteral stent transiently is still controversial.
–Pyeloplasty can be performed through one of these approaches:
•A flank, dorsal lumbotomy
•An anterior extraperitoneal approach
•Laparoscopic pyeloplasty
•Robotic assisted pyeloplasty
–The success rate of open Anderson-Hynes dismembered pyeloplasty for treating PUJ obstruction exceeds 95 %.
–There are those who use ureteral stents routinely.
–Others prefer using a double “J” stent.
–The use of perianastomotic drain following the repair is also controversial.
–The routine use of nephrostomy is also controversial.
–While open pyeloplasty is still considered the standard treatment of UPJ obstruction in infants, laparoscopic pyeloplasty, with or without robotic assistance, is the treatment of choice in older children and in most adults.
•Laparoscopic pyeloplasty:
–Traditionally, PUJ obstruction has been repaired with an open pyeloplasty.
–Laparoscopic pyeloplasty was first introduced in adults in 1993 by Schuessler.
Surgical Treatment for PUJ Obstruction
•Open pyeloplasty
•Laparoscopic pyeloplasty
•Percutaneous endopyelotomy
•Retrograde endopyelotomy
•Endopyeloplasty
•Robotic-assisted laparoscopic pyeloplasty
•Percutaneous balloon dilatation
•Endoscopic balloon dilatation
–The success of laparoscopic pyeloplasty is comparable with those of open pyeloplasty, with success rates reported to be as high as 96–98 %.
–Laparoscopic pyeloplasty is reported to be feasible and safe in children.
–Currently, laparoscopic pyeloplasty is performed for older children.
–It is technically unfeasible in very small children and infants because of space constraints.
–Laparoscopic pyeloplasty is a technically demanding procedure that generally requires significant laparoscopic experience.
–A small intrarenal pelvis is a relative contraindication to laparoscopic pyeloplasty.
–Laparoscopic pyeloplasty being a minimally invasive technique has several advantages including:
•Shorter hospital stay
•Faster recovery
•Decreased morbidity
•Better cosmetic result
•The success rates are comparable with those of open pyeloplasty
–Laparoscopic pyeloplasty is divided according to the approach into two types:
•Transperitoneal laparoscopic pyeloplasty
•Retroperitoneoscopic laparoscopic pyeloplasty
–Laparoscopic pyeloplasty can be offered to patients with:
•Severe hydronephrosis
•Aberrant crossing vessels
•Long-segment PUJ strictures
•Secondary PUJ obstruction
94 |
|
|
|
|
|
|
|
3 Pelviureteric Junction (PUJ) Obstruction |
||||
|
|
|
|
|
|
|
||||||
|
|
• PUJ obstruction and concomitant renal |
|
and difficult suturing. |
|
|
||||||
|
|
|
calculi |
|
– |
One advantage of this technique is better |
||||||
|
|
• Anomalous and solitary kidneys. |
|
|
cosmetic results. |
|
|
|||||
|
|
• |
Failed open pyeloplasty |
|
• Endoscopic treatment of PUJ obstruction |
|||||||
|
– The success rates of transperitoneal laparo- |
(Endopyelotomy): |
|
|
|
|||||||
|
|
scopic pyeloplasty and retroperitoneo- |
– This is an endoscopic incision of the PUJ. |
|||||||||
|
|
scopic |
laparoscopic pyeloplasty |
are |
– The aim |
is to |
create a |
more |
funneled |
|||
|
|
comparable (96.4 % versus 96.6 %). |
|
|
drainage system and to bring the PUJ |
|||||||
|
– A |
skill |
full laparoscopic surgeon is |
an |
|
more dependent or below the area of |
||||||
|
|
important factor for this success rate. |
|
|
obstruction. |
|
|
|
||||
|
– |
Retroperitoneoscopic laparoscopic pyelo- |
– |
Endoscopic incision is performed through |
||||||||
|
|
plasty takes more operative time when |
|
the obstructing segment of the PUJ. |
||||||||
|
|
compared with transperitoneal laparo- |
– This is performed either as: |
|
|
|||||||
|
|
scopic pyeloplasty owing to the limits of |
|
• |
An |
antegrade |
(percutaneous) |
|||||
|
|
working space and more difficult |
|
|
endopyelotomy |
|
|
|||||
|
|
suturing. |
|
|
|
• A retrograde (endoscopic) endopyelot- |
||||||
|
– |
Transperitoneal laparoscopic pyeloplasty |
|
|
omy via a ureteroscope |
|
|
|||||
|
|
on the other hand is known to be associated |
– In a percutaneous endopyelotomy, a small |
|||||||||
|
|
with: |
|
|
|
incision is made in the flank through which |
||||||
|
|
• A significantly greater postoperative |
|
a scope is advanced through the kidney into |
||||||||
|
|
|
pain |
|
|
|
the renal pelvis to incise the UPJ. |
|
||||
|
|
• A higher requirements for analgesics |
– |
Ureteroscopic |
endopyelotomy |
involves |
||||||
|
|
• A higher rate of temporary ileus |
|
|
passing a scope through the urethra, blad- |
|||||||
|
|
• A longer hospital stay |
|
|
der and ureter to incise the PUJ. |
|
||||||
|
– |
It is now recommended that open pyelo- |
– |
The endopyelotomy incision is performed |
||||||||
|
|
plasty is the procedure of choice in infants |
|
through the area of obstruction with: |
||||||||
|
|
younger than 6 months. Laparoscopic pyelo- |
|
• |
A laser |
|
|
|
|
|||
|
|
plasty is reserved for older children and to be |
|
• |
An electrocautery |
|
|
|||||
|
|
done by skillful laparoscopic surgeons. |
|
|
• |
An endoscopic scalpel |
|
|
||||
• |
Robotic-assisted laparoscopic pyeloplasty: |
|
– The vascular anatomy at the PUJ is impor- |
|||||||||
|
– |
Robotic-assisted laparoscopic pyeloplasty |
|
tant during an endopyelotomy. |
|
|||||||
|
|
has become increasingly popular to treat |
– Most vessels associated with PUJ lie in the |
|||||||||
|
|
PUJ obstruction. |
|
|
anteromedial plane but accessory vessels |
|||||||
|
– |
The da Vinci robotic surgical system has |
|
may lie posteriorly or laterally. |
|
|||||||
|
|
been used successfully to treat PUJ |
– |
If an endoscopic incision is made in the |
||||||||
|
|
obstruction. |
|
|
posterior-lateral plane, intraoperative hem- |
|||||||
|
– |
Suturing the anastomosis in the PUJ is |
|
orrhage may occur. |
|
|
||||||
|
|
much easier when compared to the laparo- |
– The best recommendation is to make sure |
|||||||||
|
|
scopic technique. |
|
|
that all incisions in the ureteral narrowing |
|||||||
|
– The results are similar to those of conven- |
|
are directed laterally to minimize the |
|||||||||
|
|
tional laparoscopic pyeloplasty. |
|
|
chance for damage to the lower pole |
|||||||
|
– It is costly and collision of the robotic arms |
|
vessel. |
|
|
|
|
|||||
|
|
in small infants is another drawback. |
|
– |
Prior to incising a PUJ obstruction, it is |
|||||||
• |
Single-port pyeloplasty: |
|
|
important to evaluate adjacent ureteral vas- |
||||||||
|
– In this technique, laparoscopic pyeloplasty |
|
culature using either an intraluminal ultra- |
|||||||||
|
|
is performed via a single port placed at the |
|
sonography, CT-scan or MRA. |
|
|||||||
|
|
umbilicus. |
|
– |
Endopyelotomy is contraindicated in the |
|||||||
|
– |
This is technically challenging owing to |
|
presence of a crossing posterior or lateral |
||||||||
|
|
instrument crowding, loss of triangulation, |
|
vessel (Figs. 3.45 and 3.46). |
|
3.8 Treatment |
95 |
|||
|
|
|
|
|
|
|
|
|
|
|
URETER |
|
ABERRANT |
|
|
|
|
VESSEL |
|
|
|
|
|
|
ABERRANT |
URETER |
VESSEL |
Figs. 3.45 and 3.46 Intraoperative photographs showing an aberrant vessel crossing and compressing the ureter leading to PUJ obstruction
–The endoscopic incision should be performed full-thickness through the PUJ and into perirenal fat.
–To ensure a proper adequate incision, extravasation of contrast should be seen on pyelography during the procedure.
–Most surgeons dilate the newly incised area with a balloon catheter to help ensure a complete incision.
–This is followed by prolonged ureteral stenting, for a period of 4–8 weeks. The stent help keeps the incised PUJ open and maintains renal drainage.
–Endopyelotomy is a reasonable option in patients with mild-to-moderate hydronephrosis and reasonably good renal function.
–The area of stricture should be short (<1.5 cm), and no crossing vessels should be defined on preoperative or intraoperative imaging.
–Endopyelotomy is also particularly useful following a failed open or laparoscopic pyeloplasty.
–The success rates with the percutaneous and ureteroscopic endopyelotomy are 80–90 %.
•Endopyeloplasty:
–This was first reported in 2002 by Gill et al from the Cleveland clinic.
–The procedure is performed through a percutaneous tract via a 26 F nephroscope.
–It consists of horizontal suturing of a standard vertical endopyelotomy incision.
–Indications for endopyeloplasty include:
•A short-segment PUJ obstruction
•Absence of crossing renal polar vessels
•No prior surgery in the PUJ.
–The results of endopyeloplasty are comparable to those of endopyelotomy.
•Ureterocalicostomy:
–A partial nephrectomy is performed and the ureter is anastomosed to a lower-pole renal calyx.
–This is usually reserved for patients following a failed open pyeloplasty when no extrarenal pelvis and significant hilar scarring are present.
• Balloon dilatations of PUJ obstruction (Figs. 3.47 and 3.48):
–Balloon dilatation of PUJ obstruction was first done in 1982 by Kadir et al in 1982.
–Balloon dilatation can be done antegrade, retrograde or combined and the success rate is variable.
–Percutaneous or endoscopic balloon dilatation of PUJ is another alternative to treat PUJ obstruction in children.
96 |
3 Pelviureteric Junction (PUJ) Obstruction |
|
|
Guide wire insertion
Pelvis Puncture – U/S guided
|
|
Balloon over guidewire |
J-J stent insertion |
Flow check |
Inflated |
|
|
Fig. 3.47 Clinical and radiological pictures showing the steps of percutaneous balloon dilatation of PUJ obstruction. A double J-stent is left in place for 6–8 weeks
Fig. 3.48 Radiological photographs showing abolishing the wasting at the PUJ which is an important prognostic sign
– |
This is performed by interventional |
– |
A double “J” stent is passed percutaneously |
|
radiologist. |
|
and left in place to keep the dilated site patent. |
– |
The site of obstruction is defined and the |
– |
Balloon dilatations are most appropriate |
|
stricture is dilated with balloon dilators. |
|
in pediatric populations because they are |